Getting closer to P-selectin

Clinical Chemistry

Volumn 55, Issue 6, 2009, Pages 1051-1052

  Chasman, Daniel I ^a   Paré, Guillaume ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; P SELECTIN GLYCOPROTEIN LIGAND 1; PADGEM PROTEIN;

ATHEROGENESIS; ATHEROSCLEROSIS; AUTOIMMUNITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORRELATION ANALYSIS; EDITORIAL; ENDOTHELIUM; FLOW CYTOMETRY; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HERITABILITY; HUMAN; INFLAMMATION; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PROTEIN EXPRESSION; SELP GENE; SELPLG GENE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE MEMBRANE;

ANIMALS; HUMANS; MICE; P-SELECTIN; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN BINDING; VASCULAR DISEASES;

EID: 66449115196     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2009.125518     Document Type: Editorial

References (6)

1. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-1695
2. Volcik KA, Catellier D, Folsom AR, Matijevic N, Wasserman B, Boerwinkle E. SELPand SELPLGgenetic variation is associated with cell surface measures of SELP and SELPLG: The Atherosclerosis Risk in Communities Carotid MRI Study. Clin Chem 2009;55:1076-1082
3. Burger PC, Wagner DD. Platelet P-selectin facilitates atherosclerotic lesion development. Blood 2003;101:2661-2666 (Pubitemid 36857627)
4. Reiner AP, Carlson CS, Thyagarajan B, Rieder MJ, Polak JF, Siscovick DS, et al. Soluble P-selectin, SELP polymorphisms, and atherosclerotic risk in European- American and African-African young adults: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Arterioscler Thromb Vasc Biol 2008;28:1549-1555
5. Volcik KA, Ballantyne CM, Coresh J, Folsom AR, Boerwinkle E. Specific P-selectin and P-selectin glycoprotein ligand-1 genotypes/haplotypes are associated with risk of incident CHD and ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis 2007;195:e76-82.
6. Toubi E, Shoenfeld Y. The role of CD40-CD154 interactions in autoimmunity and the benefit of disrupting this pathway. Autoimmunity 2004;37:457-464 (Pubitemid 40123415)